等待開盤 09-23 09:30:00 美东时间
+0.040
+1.11%
Bank of America Securities analyst Lucca Brendim maintained a Hold rating on VT...
08-27 00:35
今日重点评级关注:摩根大通:维持Ultragenyx Pharmaceutical"超配"评级,目标价从75美元升至80美元;瑞杰金融:维持英伟达"强力买入"评级,目标价从330美元升至352美元
08-26 08:37
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Itau BBA analyst Thiago Kapulskis downgraded VTEX (NYSE:VTEX) from Outperform to Market Perform a...
08-25 23:49
Itau BBA analyst Thiago Kapulskis downgrades Vtex (NYSE:VTEX) from Outperform to Market Perform and announces $4.5 price target.
08-25 20:08
Shares of companies in the broader tech sector are trading lower amid possible ...
04-24 03:45
今日重点评级关注:LUCID CAPITAL MARKETS:上调INmune Bio评级至"买入" 目标价从2美元升至9美元;Clear Street:维持MoonLake Immunotherapeutics Class A"买入"评级,目标价从45美元升至70美元
03-12 12:34
Banco Bradesco BBI S.A analyst Daniel Federle upgrades Vtex (NYSE:VTEX) from Neutral to Outperform and announces $5 price target.
03-11 19:03
VTEX shares are trading higher after the company reported better-than-expected ...
02-27 23:39
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据VTEX业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **营收表现:** - Q4订阅收入:6,670万美元,同比增长12.2%(美元计价)、5.4%(汇率中性) - 全年订阅收入:2.349亿美元,同比增长7.9%(美元计价)、9.5%(汇率中性) - GMV:Q4达63亿美元,同比增长17.2%(美元计价)、10%(汇率中性);全年205亿美元,同比增长12.1%(美元计价)、12.9%(汇率中性) **盈利能力:** - Q4订阅业务毛利率:81.8%,较上年同期78.8%提升3个百分点 - Q4总毛利率:79.6%,较上年同
02-27 12:01
The Q4 earnings report for Vtex (NYSE:VTEX) was released on Thursday, February ...
02-27 05:04